ArticleBMJ open2025

Effects and safety of dapagliflozin in paediatric hereditary kidney disease: protocol for a multicentric, prospective, open and randomised crossover study (DAPA-PedHKD).

Wei Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.